Laxmi Organic Industries share price today

Laxmi Organic Industries Ltd's share price was ₹161.98 at the close on 4 November 2026. It has been rising for 13 weeks. That is 3.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹112 and ₹195, and at that close it sat 60% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Laxmi Organic Industries Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 3 weeks running.

Over the last 5.6 years the share price moved −13% while the NIFTY 500 moved +78%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 16 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

1. Best operating margin in 15 quarters

   Operating margin was 12% in the June 2026 quarter, against 4.4% a year earlier.

   Next results: check whether Essentials keeps its margin near 11% to 12% and its spread, the gap between raw material cost and selling price, above the long-run average.

   From the earnings call on 30 Jul 2026.

3. Highest quarterly profit in 15 quarters

   Profit of ₹68 crore in the June 2026 quarter is the highest of the last 15 quarters.

   Next results: check the extra ₹7 to ₹7.5 crore quarterly depreciation charge, the accounting cost for the new plant.

   From the earnings call on 30 Jul 2026.

For April to June 2026 (the quarter ended 30 June 2026), Laxmi Organic Industries reported revenue of ₹968 crore, up 39.7% from ₹693 crore a year earlier, and a profit of ₹68.0 crore, up 223.8% from ₹21.0 crore.

Laxmi Organic Industries results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Laxmi Organic Industries' management discussed these results on a call held on 30 July 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Laxmi Organic Industries closed at ₹161.98 on 4 November 2026, down 16.9% from ₹194.88 a year earlier (7 November 2025) and down 62.4% over five years. Its highest weekly close since March 2021 was ₹549.35 on 8 October 2021.

Laxmi Organic Industries share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

298 weekly closes from 26 March 2021 to 4 November 2026.

4 Nov 2026: Laxmi Organic Industries closed at ₹161.98, up 6.0% on the week and down 10.7% on the month. Our read, 10 Oct 2026: A specialty chemical capacity build is about to start earning, but the latest profit jump came from a temporary raw-material spread, not from the new plants.

Earlier

• 30 Jul 2026: Laxmi Organic Industries held its results call for April to June 2026. Management guided: Dahej Phase 2 mechanical completion and stabilization planned in October to December 2026, customer qualification in Q3, and ramp-up in January to March 2027.
• 21 Jul 2026: ex-date for a dividend of ₹0.30 a share.
• Results for April to June 2026: Revenue up 39.7% and profit up 223.8% on a year earlier.

Our read of the business

April to June 2026: Profit triples on a spread windfall; Dahej Phase 2 slips again.

Our read after the April to June 2026 results, written 10 October 2026.

Laxmi Organic Industries paid ₹0.30 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.19% at the ₹161.98 close on 4 November 2026. The last was a dividend of ₹0.30 a share, ex-date 21 July 2026.

Laxmi Organic Industries dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Yes. Laxmi Organic Industries Ltd paid out 10% of its profit as dividends in FY26, and it paid a dividend in 7 of its last 12 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 30 July 2026, Laxmi Organic Industries' management guided: Dahej Phase 2 mechanical completion and stabilization planned in October to December 2026, customer qualification in Q3, and ramp-up in January to March 2027.

“With this expansion, we become the number 3 producer of diketene derivatives globally.”Dr. Rajan Venkatesh, on the call for April to June 2026

What management guided

• Dahej Phase 2 is intended to double diketene derivative capability.
• Approximately 85.0% of Phase 2 capital spending to be capitalized in July to September 2026; total FY27 capital spending including Dahej ₹125-150 crores.
• Dahej revenues expected to flow in FY28, with ramp-up focus on FY29 and no quantified amount.
• Project Vayu mechanical completion anticipated in early Q3, partner ramp thereafter, and FY28 capacity available for scale-up.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 30 July 2026.

What is changing at Laxmi Organic Industries, from the latest results and calls: dahej phase 2 diketene expansion, essentials spread and volume and hitachi vayu sf6-alternative product.

• Dahej Phase 2 diketene expansion. Doubles diketene derivative capability and lifts Specialty mix from FY28. ✓ fact
• Essentials spread and volume. Commodity acetyls earn above-normal spreads now, with about 10% volume growth. ✓ fact
• Hitachi Vayu SF6-alternative product. A take-or-pay partner product guided to commercialize in October to December 2026. ✓ fact
• Lote fluorination ramp. Met its FY26 goal of 42-45% of peak revenue. ✓ fact

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown.

Our read after the April to June 2026 results, written 10 October 2026.

Customer qualification has not started by the Mar 2027 quarter, or Phase 2 revenue in FY28 is too small to lift the Specialty share of revenue.

Each change stops working if

• Dahej Phase 2 diketene expansion: Customer qualification has not started by the Mar 2027 quarter, or Phase 2 revenue in FY28 is too small to lift the Specialty share of revenue.
• Essentials spread and volume: Ethyl acetate spreads fall back to the 150-160 dollar range seen in May 2026.
• Hitachi Vayu SF6-alternative product: Partner ramp-up is deferred beyond FY28 or the contract volume is cut.
• Lote fluorination ramp: FY27 fluorination revenue does not grow on FY26.

The main risks

• : Margins sit in the upper part of the spread cycle and are likely to fall back. ⚠ estimate
• : Dahej Phase 2 has slipped twice and other guidance has shifted. ⚠ estimate
• : Idle capital and a depreciation step-up weigh on earnings before Dahej earns. ⚠ estimate
• : Specialty margins may not return to the old 20-25% band. ⚠ estimate

Our read after the April to June 2026 results, written 10 October 2026.

When Laxmi Organic Industries reports July to September 2026, these are the 3 checks that show whether the story is still on course. First: Q2 Dahej capitalization should reach approximately 85.0% of Phase 2 capital spending; Q3 mechanical completion and incremental ₹7.0-7.5 crores quarterly depreciation remain key checks.

Laxmi Organic Industries is on one of our India lists: Multibagger study list.

Laxmi Organic Industries Ltd earned ₹68.0 Cr of net profit in the Jun 2026 quarter, +223.8% on the same quarter a year earlier. Full-year FY26 profit was ₹79.0 Cr. Over 10 years profit has grown 11.3% a year on average. That is 7.0% of the quarter's revenue. The same quarter a year earlier earned ₹21.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹79.0 Cr (−30.7% on the year before).

Why profit moved: revenue changed +39.7% on a year earlier and the margin moved +7.6 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed +37.3% and revenue +6.4%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

Laxmi Organic Industries Ltd reported ₹968 Cr of revenue in the Jun 2026 quarter, +39.7% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 10 years it has grown 10.5% a year on average. The last full year, FY26, came in at ₹2,847 Cr.

Revenue is everything the company billed its customers in the period.

Why this happened. Lote reached the guided 40-50% of peak revenue in FY26, one of the few dated promises kept. The peak-revenue figure itself is unclear because the Jan 2026 call cited 700-800 crore against about 80 crore three months earlier.

The last four reported quarters add to ₹3,122 Cr.

FY26 revenue was ₹2,847 Cr, −4.6% on the year before.

Recent pace: the last four quarters grew +6.4% on average, against 10.5% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +5.5%, against +4.6% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +26.0%, against +4.2% a year (accelerating).

Laxmi Organic Industries Ltd's operating margin was 12.0% in the Jun 2026 quarter, 7.6 percentage points higher than the same quarter a year ago. Across 12 years it has been between 6.0% and 12.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why this happened. Essentials revenue rose 50% in Q1 FY27 on double-digit volume and a spread above its 12-year average. Roughly 70% of Essentials supplies in India. This driver is cyclical: management calls mid-single-digit margins fair over a cycle and expects acetic acid supply to stay long through 2028, so producers and customers will compete the spread back down.

Why the margin moved: operating margin changed +7.4 percentage points on the year while gross margin changed +7.5 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 269% of Laxmi Organic Industries Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹175 Cr of operating cash against ₹79.0 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹646 Cr of spending on assets, free cash was −₹471 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 269% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle.

What to look at next: the bigger use of cash is spending on new assets, at 4.2× depreciation over three years. The next section checks what that spending is building.

Laxmi Organic Industries Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was −3 days in FY26, down from 5 days in FY21. It spent ₹1,279 Cr on assets over the last 3 years. Customers take 67 days to pay, and stock sits for 70 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Why this happened. This is the capex inflection point and a value-chain climb in one: about 85% of Phase 2 capex capitalizes in Q2 FY27, mechanical completion is planned in Q3, and customer qualification and ramp follow, with revenue in FY28. Specialty carried 20-25% margins historically against 12-13% now, so mix shift is where durable margin comes from. Customers, not the company, set the pace through qualification cycles, and the schedule has already slipped twice.

At FY26 sales of ₹2,847 Cr, each day of that cycle ties up about ₹7.8 Cr, so roughly −₹23.0 Cr is tied up in the business at any time.

FY26: customers took 67 days to pay and stock sat for 70 days, about 2.3 months of sales sitting as stock, for a full cycle of −3 days, shorter than FY21's 5.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 70 days. Customers pay about 67 days after that. Suppliers are paid at 140 days. Together that makes the −3-day cycle.

Spending on assets: ₹1,279 Cr over the last 3 years, against ₹308 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹652 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Laxmi Organic Industries Ltd's P/E is 35.8×, near the low end of its own history: it has been lower only 10% of the time. Its usual P/E (the middle reading) is 54.3×, over 5.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

Why the multiple is where it is: over the past year earnings per share moved −30.2% while the price moved −16.9%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 5 years the price moved −17.8% a year; about −1.3% a year came from earnings growth and about −16.5 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.

Worked out from its price on 11 October 2026, Laxmi Organic Industries Ltd's share price assumed profit growth of about 25.8% a year. Over the past 10 years its profit actually grew 11.3% a year. Today its P/E is 35.8×, lower than 90% of its own last 5.6 years.

This works the share price backwards. It asks one question: what yearly profit growth does the price already assume? The answer is the growth rate at which eleven years of profit (six years of growth, then five years of slowing) add up to that day's market value, after each year is discounted at 11%.

This is a one-day reading, taken on 11 October 2026. Every other number on this page, the multiple included, uses the latest price as of 4 November 2026. A higher price assumes more growth and a lower price less, so it changes whenever the price changes, and this page does not update it between measurements.

Laxmi Organic Industries Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE rising at 8.3%; each line tells part of the story. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: when the lines disagree, each line above matters more than any single label.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Laxmi Organic Industries Ltd's story is not scored yet against the checks our research set on 10 October 2026. Where it sits in its own cycle: EARLY EXPANSION.

NOT YET CHECKED

Our read, 10 October 2026. A specialty chemical capacity build is about to start earning, but the latest profit jump came from a temporary raw-material spread, not from the new plants.

From the numbers. Earnings are turning up off a trough that bottomed in Sep-Dec 2025, but the turn so far is spread-led.

From the price. Price stage 2, week 13, below its 200-day line, relative strength falling.

From the research. A specialty chemical capacity build is about to start earning, but the latest profit jump came from a temporary raw-material spread, not from the new plants.

Where they disagree. Earnings are turning up off a trough that bottomed in Sep-Dec 2025, but the turn so far is spread-led. Margins sit in the upper part of the spread cycle while the new capacity has not yet earned.

What is proven. A specialty chemical capacity build is about to start earning, but the latest profit jump came from a temporary raw-material spread, not from the new plants.

What is not proven yet. If Dahej Phase 2 is not mechanically complete with customer qualification under way by the Dec 2026 quarter call, while consolidated OPM falls back below 7% as spreads normalize, the lasting specialty unlock is not arriving on any useful timeline.

What would change our mind. If Dahej Phase 2 is not mechanically complete with customer qualification under way by the Dec 2026 quarter call, while consolidated OPM falls back below 7% as spreads normalize, the lasting specialty unlock is not arriving on any useful timeline.

The test written in advance. If Dahej Phase 2 is not mechanically complete with customer qualification under way by the Dec 2026 quarter call, while consolidated OPM falls back below 7% as spreads normalize, the lasting specialty unlock is not arriving on any useful timeline. Measured by: the thesis as written as stated by the next result.

What the company does. Dahej Phase 2 will roughly double diketene derivative capacity and make the company the third-largest producer globally, with revenue guided from FY28. The Jun 2026 quarter tripled profit, but almost all of it came from ethyl acetate spreads that management itself calls above normal.

The key numbers to watch, and the level that would change the picture

Everything further down this page is evidence for or against these.

What the surface reading misses. The surface reading is: Profit more than tripled in a year, so the earnings turn looks real and accelerating. The research reads it further: The jump is mostly a raw-material spread windfall, not a durable step-up. Gross margin rose from 22.05% to 29.55% while volume grew only about 10%, and management says the ethyl acetate spread ran above its 12-year average because of the West Asia supply shock. The Jun 2025 base was also flattered by a tax credit, so the base and the latest quarter both carry noise. New Dahej specialty capacity has not yet contributed revenue.

What the surface reading misses. But the normalization uses 9.7% OPM while management calls mid-single-digit Essentials margins fair over a cycle, so the normalized EPS is generous rather than conservative.

• 1 · Operating leveragequiet
• 2 · Value-added mixbuilding
• 3 · Management changequiet
• 4 · Paying down debtquiet
• 5 · Regulatory approvalquiet
• 6 · Order-book winsquiet
• 7 · Consolidationquiet
• 8 · Demerger or value unlockquiet
• 9 · Buybackquiet
• 10 · New geographiesquiet
• 11 · More business from existing customersquiet
• 12 · New product launchquiet
• 13 · Mandatory normsquiet
• 14 · A bigger market to servequiet
• 15 · Market-share gainsquiet
• 16 · Asset qualityquiet

Lever 2 · Value-added mix: building. Doubles diketene derivative capability and lifts Specialty mix from FY28. What proves it keeps working: Dahej Phase 2 diketene expansion. It stops working if Customer qualification has not started by the Mar 2027 quarter, or Phase 2 revenue in FY28 is too small to lift the Specialty share of revenue.

Sources: our stock research file (10 October 2026) · quarterly results through Jun 2026 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.

The whole page in one table. Each row links to its section.

What Laxmi Organic Industries Ltd's management promised, against what actually happened: 4 promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.

Dahej Phase 2 Timeline Pushed Back · 30 July 2026. The Jan 2026 call planned completion of Dahej Phase 2 by the end of Q4 FY26, while the May 2026 call expected chemical charging in Q1 FY27 and revenue contribution in the second half of FY27. The Jul 2026 call now places mechanical completion and stabilization in Q2-Q3 FY27, customer qualification in Q3, and ramp-up in Q4, representing a material schedule slippage without explaining what caused the change.

Fluorination Revenue Guidance Contradiction · 30 January 2026. In the October 2025 call, management explicitly agreed with an analyst's estimate of approximately INR 80 crores for Fluorochemical revenues in FY26, confirming no change to the outlook. However, in the January 2026 call, management stated they are aiming for and 'chugging toward' a top line of 700 to 800 crores for fluorination, a discrepancy of nearly 10x that completely contradicts the prior quarter's specific guidance. Earlier call (Oct 2025): “Nitesh Dhoot:.likely to be about INR 80-odd crores in FY”. Later call (Jan 2026): “On fluorination, we were targeting a top line of 700 to 800 crores, and we are chugging toward that range. This is a positive development.”

Disappearance of Deferred Delivery Catalyst · 30 January 2026. In both July and October 2025, management emphasized that revenue weakness was partly due to deferred deliveries (approx. 4% of sales) which would shift to and benefit H2 FY26. In the January 2026 call (Q3, part of H2), Specialty revenue declined 30%, but management failed to mention the realization of these deferred deliveries as an offset; instead, they introduced a previously unmentioned headwind regarding a 'one-time campaign product' (5-6% impact) to explain the drop. Earlier call (Oct 2025): “.deferred deliveries to global customers, which will now happen in the second half. So in this half of the financial year, between quarter 3 and quarter 4.” Later call (Jan 2026): “In specialty, revenue declined by 30%. a one-time campaign product in FY25 caused a 5-6% decline.”

Lowered Expectations for Fluorochemicals Ramp-up · 30 October 2025. In prior calls, management consistently guided for the new fluorochemicals project to achieve 40% to 60% of its peak revenues in FY26. However, in the October 2025 call, this guidance was revised down to 40% to 50%, removing the upper end of the range without explanation and signaling a less optimistic outlook on the project's near-term contribution. Earlier call (May 2025): “the ambition continues to be that into FY”. Earlier call (Jul 2025): “we remain on target to achieve, as we have always called out in FY26, somewhere between 40% to 60% of the peak revenues.” Later call (Oct 2025): “we are anticipating to have revenues which is closer to the 40 to 50% of the peak revenues that we had called out in the past.”

Every quote above is taken word for word from the company’s own earnings calls.

Lote delivered within its guided ramp range, while Dahej and Vayu dates moved and the fluorination revenue goal is inconsistent across machine summaries.

Regulatory and governance record

No company-specific fraud finding, conduct order or named material live case surfaced.

Checked 14 October 2026.

Laxmi Organic Industries Ltd earned a ROCE of 5% in FY26. Its return on capital used (ROIC) is 6.0 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 2.8% net margin and 0.83× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 2.8% net margin × 0.83× asset turnover × 1.73× leverage (assets divided by equity) ≈ 4.0% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 6.0% − 12.0% = −6.0 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

The 6.0% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 4.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

Laxmi Organic Industries Ltd has total debt of ₹543 Cr against shareholder equity of ₹1,986 Cr as of Jun 2026, so its debt is 0.27× its equity, which is very little. Year by year, that ratio went from 0.11 in FY22 to 0.27 in FY26. So the returns on this page come from the business, not from borrowed money.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

No group of Laxmi Organic Industries Ltd's owners changed its stake by a full percentage point over the last two years. Promoters moved −0.3 points over the same period, to 69.2%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Foreign institutions: −0.7 points over 8 quarters, to 0.9%; Promoters: −0.3 points over 8 quarters, to 69.2%; Domestic institutions: −0.2 points over 8 quarters, to 3.1%.

For Laxmi Organic Industries Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

54.2 out of 100, rank 8 of 20 in Chemicals - Organic, with 81% of the evidence available.

Laxmi Organic Industries Ltd scores 54.2 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 8. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 21.1 + 10.8 + 13.1 + 9.2 = 54.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Laxmi Organic Industries ranks 8 of 20 Chemicals - Organic companies on the 4-Factor Sector Score, with 54.2 out of 100.